These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2082904)

  • 21. [Update: clinical lipidology].
    Parhofer KG
    MMW Fortschr Med; 2013 Jul; 155(13):49-52; quiz 53-4. PubMed ID: 23964509
    [No Abstract]   [Full Text] [Related]  

  • 22. Who decides when to start preventive treatment? A questionnaire survey to compare the views of different population subgroups.
    Lewis DK; Barton S
    J Epidemiol Community Health; 2003 Apr; 57(4):241-2. PubMed ID: 12646536
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of high blood cholesterol in patients with coronary heart disease].
    Nagai Y; Yanagi K; Yamashita S; Takemura K; Matsuzawa Y
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):1088-94. PubMed ID: 12436661
    [No Abstract]   [Full Text] [Related]  

  • 24. [Statins (HMG-CoA reductase inhibitors)].
    Gotoda T
    Nihon Rinsho; 2006 Nov; 64(11):2113-8. PubMed ID: 17087305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy and clinical trials.
    Ogunko A; Evans M
    Curr Opin Lipidol; 1998 Dec; 9(6):617-8. PubMed ID: 10075483
    [No Abstract]   [Full Text] [Related]  

  • 26. Hyperlipidaemia and coronary risk. The Scottish Lipid Consensus Group.
    Scott Med J; 1991 Aug; 36(4):99-103. PubMed ID: 1815558
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of fenofibrate on serum lipoproteins in subjects with familial hypercholesterolemia and combined hyperlipidemia.
    Weisweiler P; Merk W; Janetschek P; Schwandt P
    Atherosclerosis; 1984 Dec; 53(3):321-5. PubMed ID: 6529448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coronary artery disease and diabetes.
    Bohannon NJ
    Postgrad Med; 1999 Feb; 105(2):66-8, 71-2, 77-80. PubMed ID: 10026704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Focus on fenofibrate.
    Brown WV
    Hosp Pract (Off Ed); 1988 Jun; 23 Suppl 1():31-40. PubMed ID: 3134383
    [No Abstract]   [Full Text] [Related]  

  • 30. Hyperlipidaemia and cardiovascular disease.
    Wray R
    Curr Opin Lipidol; 1997 Aug; 8(4):U54-5. PubMed ID: 9253546
    [No Abstract]   [Full Text] [Related]  

  • 31. [Coronary risk in Spain and its treatment with lipid-lowering drugs].
    Maiques Galán A; Villar Alvarez F; Llor Vila C; Torcal Laguna J
    Aten Primaria; 2003 Oct; 32(7):420-2. PubMed ID: 14622555
    [No Abstract]   [Full Text] [Related]  

  • 32. Hyperlipidemia after cardiac transplantation: be aware and possibly wary of drug therapy for lowering of serum lipids.
    Butman SM
    Am Heart J; 1991 May; 121(5):1585-90. PubMed ID: 2018001
    [No Abstract]   [Full Text] [Related]  

  • 33. Updating a 12-year experience with arrest and reversal therapy for coronary heart disease (an overdue requiem for palliative cardiology).
    Esselstyn CB
    Am J Cardiol; 1999 Aug; 84(3):339-41, A8. PubMed ID: 10496449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fenofibrate].
    Yamashita T; Nakamura H
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():618-24. PubMed ID: 11347142
    [No Abstract]   [Full Text] [Related]  

  • 35. Selection of appropriate type and intensity of lipid-lowering therapy.
    Tikkanen MJ
    Curr Opin Lipidol; 1995 Dec; 6(6):360-4. PubMed ID: 8750248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of hyperlipidaemia.
    Drug Ther Bull; 1996 Dec; 34(12):89-93. PubMed ID: 9018924
    [No Abstract]   [Full Text] [Related]  

  • 37. After the meta-analyses: a commentary on treatment of dyslipidaemia in the primary prevention of coronary heart disease.
    Silberberg JS
    Aust N Z J Med; 1994 Dec; 24(6):717-21. PubMed ID: 7717926
    [No Abstract]   [Full Text] [Related]  

  • 38. [Lipid lowering therapy for primary prevention of coronary heart disease--contra lipid lowering therapy].
    Berger M
    Z Kardiol; 1998; 87 Suppl 2():210-3. PubMed ID: 9827485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Efficacy and safety of combined statin-fenofibrates therapy compared with monotherapy in patients with mixed hyperlipidemia and high risk of coronary heart disease].
    Kłosiewicz-Latoszek L; Respondek W; Białobrzeska-Paluszkiewicz J; Grzybowska B; Jakóbisiak-Ostasz B; Stolarska I
    Pol Merkur Lekarski; 2003 Jul; 15(85):42-6. PubMed ID: 14593958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of creatine kinase elevation during treatment with fluvastatin in combination with fibrates (bezafibrate, fenofibrate, or gemfibrozil).
    Farnier M; Bortolini M; Salko T; Freudenreich MO; Isaacsohn JL; Troendle AJ; Gonasun L
    Am J Cardiol; 2003 Jan; 91(2):238-40. PubMed ID: 12521642
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.